UBS Group AG - TRXADE HEALTH INC ownership

TRXADE HEALTH INC's ticker is MEDS and the CUSIP is 89846A207. A total of 14 filers reported holding TRXADE HEALTH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TRXADE HEALTH INC
ValueSharesWeighting
Q4 2022$4,526
+13.2%
11,315
+194.7%
0.00%
Q3 2022$4,000
+300.0%
3,840
+924.0%
0.00%
Q2 2022$1,000
-88.9%
375
-87.8%
0.00%
Q1 2022$9,000
-66.7%
3,072
-43.4%
0.00%
Q3 2021$27,000
+12.5%
5,425
+0.9%
0.00%
Q2 2021$24,000
+300.0%
5,379
+363.7%
0.00%
Q1 2021$6,000
-40.0%
1,160
-32.7%
0.00%
Q2 2020$10,0001,724
+86100.0%
0.00%
Q1 2020$020.00%
Other shareholders
TRXADE HEALTH INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ridgewood Investments LLC 94,900$224,0000.14%
B. Riley Wealth Advisors, Inc. 226,553$535,0000.02%
Virtu Financial LLC 17,447$41,0000.00%
BANK OF AMERICA CORP /DE/ 6$00.00%
WELLS FARGO & COMPANY/MN 20$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 42,057$98,0000.00%
MORGAN STANLEY 5,248$12,0000.00%
BlackRock Inc. 10,823$25,0000.00%
Citadel Advisors 25,756$60,0000.00%
View complete list of TRXADE HEALTH INC shareholders